Release Summary

Strategic Science and Technologies (SST) Initiates Phase 2 Study for SST-6007, a first-in-class, topical, over-the-counter sildenafil product candidate for treatment of Female Sexual Arousal Disorder

Strategic Science and Technologies LLC